Literature DB >> 24789145

Measures of 'exposure needed for one additional patient to be harmed' in population-based case-control studies.

Jesper Hallas1, Rene Depont Christensen, Til Stürmer, Anton Pottegård.   

Abstract

PURPOSE: The magnitude of risk for adverse drug reactions may be communicated by a measure of 'exposure needed for one additional patient to be harmed' (ENH). We present four ENH measures, based on four different counterfactual contrasts, as illustrated by the known effects of NSAID use on peptic ulcer bleeding.
METHODS: The four measures were basic ENH (estimating the excess risk when treating the entire source population versus treating no one), age-restricted ENH (the entire source population above, e.g. 50 years old treated versus no one above 50 years old treated), standardised ENH (a population of similar age and gender distribution as those actually treated versus same subjects not treated) and naturalistic ENH (those actually treated versus same subjects not treated). Data were derived from a case-control dataset on NSAIDs and severe peptic ulcer bleeding, collected in Funen County in 1995-2006. We incorporated prescription and census data to account for the source population's drug use.
RESULTS: Estimates of basic, age-restricted, standardised and naturalistic ENH were 619 person-years (py) (95% confidence interval (CI): 558-684), 223 py (CI: 201-246), 131 py (CI: 118-144) and 162 py (CI: 151-173). The age-restricted ENH showed strong dependence on the chosen age limit.
CONCLUSION: The differing counterfactual contrasts underlying the ENH result in widely different estimates. These differences reflect the clinical and epidemiological aspects of NSAID-related peptic ulcer bleeding. The ultimate choice of ENH measure will depend on epidemiological or clinical considerations and on availability of data.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  NSAIDs; case-control study; pharmacoepidemiology; risk communication

Mesh:

Substances:

Year:  2014        PMID: 24789145     DOI: 10.1002/pds.3635

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  5 in total

1.  Long-Term Lithium Use and Risk of Renal and Upper Urinary Tract Cancers.

Authors:  Anton Pottegård; Jesper Hallas; Boye L Jensen; Kirsten Madsen; Søren Friis
Journal:  J Am Soc Nephrol       Date:  2015-05-04       Impact factor: 10.121

2.  Using the Symmetry Analysis Design to Screen for Adverse Effects of Non-vitamin K Antagonist Oral Anticoagulants.

Authors:  Maja Hellfritzsch; Lotte Rasmussen; Jesper Hallas; Anton Pottegård
Journal:  Drug Saf       Date:  2018-07       Impact factor: 5.606

3.  Cardiovascular drugs and erectile dysfunction - a symmetry analysis.

Authors:  Lotte Rasmussen; Jesper Hallas; Kenneth Grønkjaer Madsen; Anton Pottegård
Journal:  Br J Clin Pharmacol       Date:  2015-07-28       Impact factor: 4.335

Review 4.  Core concepts in pharmacoepidemiology: Fundamentals of the cohort and case-control study designs.

Authors:  Anton Pottegård
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-06-07       Impact factor: 2.732

5.  Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures.

Authors:  Alexander Egeberg; Peter Schwarz; Torben Harsløf; Yuki M F Andersen; Anton Pottegård; Jesper Hallas; Jacob P Thyssen
Journal:  JAMA Dermatol       Date:  2021-03-01       Impact factor: 10.282

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.